13 October 2026
Latham & Watkins Advises Cheplapharm on €1.2 Billion Term Loan B
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jan Penselin Lead | Latham & Watkins LLP | Partner | Capital Markets | Frankfurt |
| Alexandra Hagelüken Lead | Latham & Watkins LLP | Partner | Banking & Private Credit | Frankfurt |
| Cora Grannemann | Latham & Watkins LLP | Counsel | Not stated | Not stated |
| Yan Ma | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Peter Neuböck | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Tobias Müller | Latham & Watkins LLP | Associate | capital markets | Not stated |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 1.20bn (€1.2 billion)
- What the figure measures
- Facility amount
- Client
- Cheplapharm Arzneimittel GmbHBorrower
- Counterparties
- Not stated